Biliary Atresia in Northwest Iran: Epidemiologic Features and Long-Term Outcome

long-term outcome of kasai operation on children with biliary atresia between 2001-2010 in namazi hospital, shiraz, iran

background: biliary atresia is a 100% fatal disorder without any treatment in infants as a leading cause of cirrhosis and kasai operation, as the only operative choice, which plays a crucial role in increasing their rate of survival. nonetheless, many patients end up with liver transplantation in the future owing to various inevitable hepatic and biliary problems which do remain after the kasai...

the effects of keyword and context methods on pronunciation and receptive/ productive vocabulary of low-intermediate iranian efl learners: short-term and long-term memory in focus

از گذشته تا کنون، تحقیقات بسیاری صورت گرفته است که همگی به گونه ای بر مثمر ثمر بودن استفاده از استراتژی های یادگیری لغت در یک زبان بیگانه اذعان داشته اند. این تحقیق به بررسی تاثیر دو روش مختلف آموزش واژگان انگلیسی (کلیدی و بافتی) بر تلفظ و دانش لغوی فراگیران ایرانی زیر متوسط زبان انگلیسی و بر ماندگاری آن در حافظه می پردازد. به این منظور، تعداد شصت نفر از زبان آموزان ایرانی هشت تا چهارده ساله با...

long term follow-up of kasai operation for biliary atresia: a single center experience

children who are operated for biliary atresia by the kasai procedure have approximately 30% chance of survival for 5 years. in an attempt to define the role of this operation for biliary atresia, the surgery records of the past 15 years were reviewed. the aim of this study was to assess the benefits achieved from this operation in infants with biliary atresia. this study was conducted in the de...

Biliary Atresia: Current Trends in Outcome and Management.

Long -Term Outcome Therapy of Toxic Diffuse Goiter in Tehran

SUMMARY In order to evaluate the long-ter m effects of antithyroids and ahlative therapy on patients with toxic diffuse goiter (TDG) in an iodine deficient region, 206 patients were studied in Tehran. Hyperthyroidism recurred in 50%, of 80 patients treated with Methimazole (MMI), from one week to 48 months after cessation of therapy. Another 40 patients remained in remission. Of 102 patients t...